1. Home
  2. GCT vs EYPT Comparison

GCT vs EYPT Comparison

Compare GCT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GigaCloud Technology Inc

GCT

GigaCloud Technology Inc

HOLD

Current Price

$50.03

Market Cap

1.2B

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$12.49

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
EYPT
Founded
2019
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
GCT
EYPT
Price
$50.03
$12.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$33.00
$31.80
AVG Volume (30 Days)
728.4K
1.6M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
N/A
EPS
2.19
N/A
Revenue
$1,161,042,000.00
$7,539,000.00
Revenue This Year
$14.43
N/A
Revenue Next Year
$6.78
$3,115.57
P/E Ratio
$23.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.17
$9.65
52 Week High
$56.27
$19.11

Technical Indicators

Market Signals
Indicator
GCT
EYPT
Relative Strength Index (RSI) 78.49 49.67
Support Level $36.09 $11.86
Resistance Level N/A $13.32
Average True Range (ATR) 2.75 0.83
MACD 1.19 0.10
Stochastic Oscillator 79.54 47.84

Price Performance

Historical Comparison
GCT
EYPT

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: